Home › Spinal Muscular Atrophy › Texas › Lewisville
Spinal Muscular Atrophy clinical trials in Lewisville, TX
4 studies for Spinal Muscular Atrophy are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RecruitingPhase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi away
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RecruitingPhase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi away
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
RecruitingPhase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi away
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
RecruitingPhase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi away
About Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) attacks nerve cells in the spinal cord, weakening voluntary muscles. Read about the genetics, types, and what may help.
More about Spinal Muscular Atrophy on MedlinePlus
Spinal Muscular Atrophy trials in other cities
- Mountain View, CA9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Norfolk, VA6 studies
- Chicago, IL6 studies
- Grand Rapids, MI6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Little Rock, AR4 studies
- Phoenix, AZ4 studies
- Aurora, CO4 studies
- Memphis, TN3 studies
Other studies in Lewisville
- Ulcerative Colitis10 studies
- Crohn's Disease9 studies
- Breast Cancer5 studies
- Type 2 Diabetes5 studies
- Digestive Diseases4 studies
- Inflammatory Bowel Disease4 studies
- Colorectal Cancer3 studies
- Steatotic Liver Disease3 studies
- Triple-Negative Breast Cancer3 studies
- Metastatic Cancer3 studies
- Lung Diseases3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.